The U.S. Food and Drug Administration today announced a pilot program designed to streamline communications with sponsors following formal meetings. Through the program, sponsors are given a “Meeting ...
Judge Pauline Newman has served with distinction on the U.S. Court of Appeals for the Federal Circuit since her appointment ...
The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...
The U.S. Food and Drug Administration said on Wednesday that it has launched a pilot program to give drugmakers faster answers to follow-up questions after formal meetings with the agency.
Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for ...
“The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch. Synthesis is ...
The shift towards sustainability in drug development focuses on reducing lab waste and enhancing operational efficiency for a ...
A spokesperson for the FDA said the agency is “considering a wide range of options to support American innovation." ...
Profluent has raised $106 million to scale up use of its AI models for biology in drug development and agriculture.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback